By Joe Wallace and Gunjan Banerji U.S. stocks staged a powerful rebound following their steepest selloff since October, but recorded losses for the week. The week was marked by sharp stock swings in both directions, with a recent stock-market rally almost as strong as the initial selloff, as investors parsed inflation data. The S&P 500 rose 61.35 points, or 1.5%, to 4173.85 on Friday, with gains accelerating in the afternoon. The Dow Jones Industrial Average added 360.68 points, or 1.1%, to 34382.13. The Nasdaq Composite advanced 304.99 points, or 2.3%, to 13429.98. The gains built on a rally that began Thursday, when major indexes snapped a three-session losing streak.
Posted on 1
Hertz Global Holdings, Inc. (OTC: HTZGQ) has reported the completion of the auction previously approved by the Court in its Chapter 11 case. Hertz has chosen and approved a revised proposal from select funds and accounts managed by affiliates of Knighthead Capital Management LLC, Apollo Capital Management, LP and Certares Opportunities LLC. In the proposal, the funds and accounts will provide the equity required to fund Hertz’s revised Plan of Reorganization and exit from Chapter 11. Paul Stone, Hertz’s President and Chief Executive Officer, commented, “We are very pleased that our Plan process produced such a tremendous result for our creditors and shareholders. We appreciate the strong interest in Hertz from the competing Plan sponsors and thank them for their active engagement, which provided us with excellent options for our exit from Chapter 11. We look forward to working with the KHCA Group
Share this article
Share this article
ResearchAndMarkets.com s offering.
Growing pharmaceutical industry, increasing uptake of multifunctional excipients, and the availability of high quality raw materials and excipients are the key driving factors of the market. Furthermore, increasing chronic disease prevalence around the world enhances the demand for pharmaceutical products and thereby excipients.
Market Segmentation
Recent Developments
2020: Evonik launched RESOMER Precise platform of custom functional excipients to precisely control the release profile of parenteral drug products.
In April 2019, Colorcon, Inc. (US) signed an agreement with DuPont Nutrition and Biosciences (US) in order to enhance the current product portfolio of CR Alliance products.
[HK]海信家电:(1) 主要交易－认购三电控股株式会社定向增发的股份；及(2) 2021年第二次临时股东大会通知- CFi CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.